Beata Kaleta
About
In The Last Decade
Beata Kaleta
41 papers receiving 531 citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 131
- Rheumatology 120
- Pharmacology 95
- Plant Science 85
- Immunology 77
Countries citing papers authored by Beata Kaleta
This map shows the geographic impact of Beata Kaleta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beata Kaleta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beata Kaleta more than expected).
Fields of papers citing papers by Beata Kaleta
This network shows the impact of papers produced by Beata Kaleta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beata Kaleta. The network helps show where Beata Kaleta may publish in the future.
Co-authorship network of co-authors of Beata Kaleta
This figure shows the co-authorship network connecting the top 25 collaborators of Beata Kaleta. A scholar is included among the top collaborators of Beata Kaleta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beata Kaleta. Beata Kaleta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 4 | |
| 4 | 11 | |
| 5 | 9 | |
| 6 | 15 | |
| 7 | 12 | |
| 8 | 3 | |
| 9 | 15 | |
| 10 | 2 | |
| 11 | 36 | |
| 12 | 19 | |
| 13 | 1 | |
| 14 | 13 | |
| 15 | 8 | |
| 16 | 8 | |
| 17 | 42 | |
| 18 | Vitamin D receptor gene polymorphism in Polish patients with morbid obesity | 1 |
| 19 | 0 | |
| 20 | ["Hand-foot" syndrome--after liposomal pegylated doxorubicin in patients with the ovarian cancer recurrence (own experiences)]. | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.